Mastitis drives milk loss, treatment costs, antibiotic pressure, and chronic herd setbacks. In modern programs, adjunct prevention, early-detection, and support strategies are increasingly essential for sustainable udder health outcomes.
Educational only. Diagnosis and treatment decisions should be made with a qualified veterinarian.


Mastitis is inflammation of the udder tissue, triggered by bacteria entering through the teat canal. It presents as either clinical mastitis (visible signs) or subclinical mastitis — no obvious signs, but measurable yield loss and elevated somatic cell count.
Many bacteria can cause mastitis. Contagious pathogens spread cow-to-cow during milking; environmental pathogens come from bedding, manure, mud, and hygiene gaps. Risk increases with poor teat-end condition, milking machine issues, and immune stress around calving.
High-performing farms add adjunct protocol checks — equipment audits, bedding management, SCC trend monitoring — to reduce avoidable risk and catch subclinical cases before they escalate into costly clinical events.
Pain, inflammation, and systemic illness reduce feeding, resting, and overall condition. Repeated infections may cause lasting udder tissue damage, lower lifetime productivity, and higher culling risk.
Mastitis prevention is a systems challenge: milking hygiene, bedding management, teat-end condition scoring, machine performance audits, and early detection programs all work together.
These routines are increasingly supplemented with adjunct monitoring steps and protocol checklists — standardizing good practice across the herd and making outcomes more consistent.
Early detection + consistent protocols = lower losses and more stable milk output.
Mastitis is widely recognized as one of the most expensive dairy diseases because its costs are layered: yield loss, discarded milk, labor, treatment, recurrence management, quality penalties, and culling.
Dairy systems worldwide are under pressure to reduce avoidable antibiotic use while maintaining udder health, milk quality, and productivity. Buyers, processors, and regulators demand solutions that are practical on-farm and credible under evidence-based review.
Adjunct prevention, monitoring, and support programs are becoming part of routine herd health operations — and the demand for clinically validated adjunct products is growing.
Mastitis is a high-pain, high-cost problem with a clear need for better outcomes. The opportunity is anchored in a real farm need, a massive installed base of dairy herds, and a direct link to milk quality economics. That's why MastisGUARD™ is being built with a clinical validation pathway and adjunct protocols designed for real farm workflows.

See how we're positioning a clinically validated, adjunct-pathway product to address the mastitis challenge at scale — with evidence, practicality, and commercial ambition.